1,25-Dihydroxyvitamin/NN
D3/NN
receptor/NN
RNA/NN
:/:
expression/NN
in/IN
hematopoietic/JJ
cells/NNS
./.

1,25-Dihydroxyvitamin/NN
D3/NN
[/(
1,25(OH)2D3/NN
]/)
induces/VBZ
differentiation/NN
and/CC
inhibits/VBZ
proliferation/NN
of/IN
myeloid/JJ
leukemic/JJ
cells/NNS
from/IN
various/JJ
lines/NNS
and/CC
patients/NNS
;/:
these/DT
effects/NNS
are/VBP
probably/RB
mediated/VBN
through/IN
the/DT
1,25(OH)2D3/NN
receptor/NN
./.
=====
Little/JJ
is/VBZ
known/VBN
of/IN
expression/NN
of/IN
1,25(OH)2D3/NN
receptor/NN
RNA/NN
in/IN
hematopoietic/JJ
cells/NNS
./.
=====
We/PRP
examined/VBD
the/DT
expression/NN
and/CC
modulation/NN
of/IN
expression/NN
of/IN
1,25(OH)2D3/NN
receptor/NN
RNA/NN
in/IN
various/JJ
proliferating/VBG
and/CC
nonproliferating/JJ
hematopoietic/JJ
cells/NNS
./.
=====
Constitutive/JJ
expression/NN
of/IN
1,25(OH)2D3/NN
receptor/NN
RNA/NN
was/VBD
detected/VBN
in/IN
various/JJ
kinds/NNS
of/IN
hematopoietic/JJ
cells/NNS
,/,
including/VBG
macrophages/NNS
and/CC
activated/VBN
T/NN
lymphocytes/NNS
,/,
as/RB
well/RB
as/IN
in/IN
cell/NN
lines/NNS
KG-1/NN
(/(
myeloblasts/NNS
)/)
,/,
HL-60/NN
(/(
promyelocytes/NNS
)/)
,/,
ML-3/NN
(/(
myelomonoblasts/NNS
)/)
,/,
U937/NN
,/,
THP-1/NN
(/(
monoblasts/NNS
)/)
,/,
K562/NN
(/(
erythroblasts/NNS
)/)
,/,
and/CC
S-LB1/NN
(/(
HTLV-1-transfected/JJ
T/NN
lymphocytes/NNS
)/)
./.
=====
Receptor/NN
transcripts/NNS
were/VBD
4.6/CD
kilobases/NNS
(/(
kb/NN
)/)
,/,
and/CC
no/DT
variant/JJ
sizes/NNS
were/VBD
observed/VBN
./.
=====
All/DT
cell/NN
lines/NNS
examined/VBN
in/IN
this/DT
group/NN
also/RB
expressed/VBD
1,25(OH)2D3/NN
receptors/NNS
./.
=====
Most/JJS
B/NN
lymphocyte/NN
lines/NNS
expressed/VBD
negligible/JJ
levels/NNS
of/IN
1,25(OH)2D3/NN
receptor/NN
RNA/NN
and/CC
protein/NN
;/:
however/RB
;/:
analysis/NN
of/IN
a/DT
lymphoid/myeloid/JJ
somatic/JJ
hybrid/NN
suggested/VBD
that/IN
suppression/NN
of/IN
expression/NN
of/IN
1,25(OH)2D3/NN
receptor/NN
RNA/NN
in/IN
B/NN
lymphocytes/NNS
may/MD
be/VB
a/DT
dominant/JJ
characteristic/NN
./.
=====
HL-60/NN
cells/NNS
were/VBD
cultured/VBN
with/IN
10/CD
(/(
-7/CD
)/)
mol/L/NN
1,25(OH)2D3/NN
for/IN
24/CD
to/TO
72/CD
hours/NNS
,/,
and/CC
levels/NNS
of/IN
expression/NN
of/IN
1,25(OH)2D3/NN
receptor/NN
and/CC
its/PRP$
RNA/NN
were/VBD
examined/VBN
./.
=====
Levels/NNS
of/IN
RNA/NN
coding/NN
for/IN
the/DT
receptor/NN
were/VBD
not/RB
modulated/VBN
by/IN
exposure/NN
to/TO
high/JJ
levels/NNS
of/IN
ligand/NN
./.
=====
Levels/NNS
of/IN
occupied/VBN
1,25(OH)2D3/NN
receptor/NN
protein/NN
increased/VBD
in/IN
these/DT
HL-60/NN
cells/NNS
;/:
but/CC
the/DT
total/JJ
number/NN
of/IN
1,25(OH)2D3/NN
receptors/NNS
decreased/VBD
about/RB
50/CD
%/NN
at/IN
24/CD
hours/NNS
and/CC
returned/VBD
toward/IN
normal/JJ
at/IN
72/CD
hours/NNS
./.
=====
Steady-state/JJ
levels/NNS
of/IN
1,25(OH)2D3/NN
receptor/NN
RNA/NN
were/VBD
not/RB
affected/VBN
by/IN
terminal/JJ
differentiation/NN
of/IN
HL-60/NN
toward/IN
either/CC
granulocytes/NNS
or/CC
macrophages/NNS
./.
=====
Nondividing/JJ
macrophages/NNS
from/IN
normal/JJ
individuals/NNS
also/RB
expressed/VBD
1,25(OH)2D3/NN
receptor/NN
RNA/NN
./.
=====
In/IN
contrast/NN
,/,
nondividing/JJ
peripheral/JJ
blood/NN
lymphocytes/NNS
from/IN
normal/JJ
individuals/NNS
did/VBD
not/RB
express/VB
1,25(OH)2D3/NN
receptor/NN
RNA/NN
;/:
with/IN
stimulation/NN
of/IN
proliferation/NN
of/IN
these/DT
cells/NNS
,/,
accumulation/NN
of/IN
1,25(OH)2D3/NN
receptor/NN
RNA/NN
increased/VBD
markedly/RB
./.
=====
Half-life/NN
(/(
t1/2/NN
)/)
of/IN
1,25(OH)2D3/NN
receptor/NN
RNA/NN
in/IN
T/NN
lymphocytes/NNS
was/VBD
short/JJ
(/(
1/CD
hour/NN
)/)
as/IN
determined/VBN
by/IN
measuring/VBG
decay/NN
of/IN
the/DT
message/NN
after/IN
addition/NN
of/IN
actinomycin/NN
D/NN
./.
=====
Consistent/JJ
with/IN
this/DT
short/JJ
t1/2/NN
,/,
accumulation/NN
of/IN
1,25(OH)2D3/NN
receptor/NN
RNA/NN
increased/VBD
in/IN
cells/NNS
as/IN
their/PRP$
protein/NN
synthesis/NN
was/VBD
inhibited/VBN
./.
=====
Further/JJ
studies/NNS
are/VBP
required/VBN
to/TO
understand/VB
the/DT
physiologic/JJ
role/NN
of/IN
1,25(OH)2D3/NN
receptors/NNS
in/IN
myeloid/JJ
cells/NNS
and/CC
proliferating/VBG
T/NN
lymphocytes/NNS
./.